Outlook Therapeutics (OTLK) EPS (Weighted Average and Diluted) Growth (1y) (2017 - 2026)
Outlook Therapeutics (OTLK) EPS (Weighted Average and Diluted) Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-79.34% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
51.13 Mn |
43.39 Mn |
-21,888.00 |
96.67% |
| Date | Value |
|---|
| Mar 31, 2026 |
96.67% |
| Dec 31, 2025 |
-152.78% |
| Sep 30, 2025 |
-125.00% |
| Jun 30, 2025 |
38.20% |
| Mar 31, 2025 |
81.27% |
| Dec 31, 2024 |
183.72% |
| Sep 30, 2024 |
176.77% |
| Jun 30, 2024 |
44.72% |
| Mar 31, 2024 |
-1,440.38% |
| Dec 31, 2023 |
-975.00% |
| Sep 30, 2023 |
-1,550.00% |
| Jun 30, 2023 |
-1,912.50% |
| Mar 31, 2023 |
-477.78% |
| Dec 31, 2022 |
0.00% |
| Sep 30, 2022 |
25.00% |
| Jun 30, 2022 |
-14.29% |
| Mar 31, 2022 |
0.00% |
| Dec 31, 2021 |
33.33% |
| Sep 30, 2021 |
-500.00% |
| Jun 30, 2021 |
-133.33% |
